These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 10766173)

  • 21. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
    Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
    Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats--DFU and piroxicam study.
    Burdan F
    Toxicology; 2005 Jul; 211(1-2):12-25. PubMed ID: 15863244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.
    Stoner GD; Qin H; Chen T; Carlton PS; Rose ME; Aziz RM; Dixit R
    Carcinogenesis; 2005 Sep; 26(9):1590-5. PubMed ID: 15878914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of UV carcinogenesis by difluoromethylornithine in nucleotide excision repair-deficient Xpa knockout mice.
    Rebel H; van Steeg H; Beems RB; Schouten R; de Gruijl FR; Terleth C
    Cancer Res; 2002 Mar; 62(5):1338-42. PubMed ID: 11888902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.
    Okajima E; Uemura H; Ohnishi S; Tanaka M; Ohta M; Tani M; Fujimoto K; Ozono S; Okajima E; Hirao Y
    Aktuelle Urol; 2003 Jul; 34(4):256-8. PubMed ID: 14566678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice.
    Quesada CF; Kimata H; Mori M; Nishimura M; Tsuneyoshi T; Baba S
    Jpn J Cancer Res; 1998 Apr; 89(4):392-6. PubMed ID: 9617344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Piroxicam-induced regression of intestinal adenomatous polyps in APC(delta474) mice.
    Qiu ZF; Maruyama K; Sunayama K; Kashiwabara H; Shoji T; Nakamura T; Suzuki S; Konno H; Nakamura S
    J Invest Surg; 2003; 16(2):71-81. PubMed ID: 12746190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.
    Kitamura T; Itoh M; Noda T; Matsuura M; Wakabayashi K
    Int J Cancer; 2004 Apr; 109(4):576-80. PubMed ID: 14991580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
    Perkins S; Verschoyle RD; Hill K; Parveen I; Threadgill MD; Sharma RA; Williams ML; Steward WP; Gescher AJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):535-40. PubMed ID: 12050094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.
    Seno H; Oshima M; Ishikawa TO; Oshima H; Takaku K; Chiba T; Narumiya S; Taketo MM
    Cancer Res; 2002 Jan; 62(2):506-11. PubMed ID: 11809702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil.
    Nigro ND; Bull AW; Boyd ME
    J Natl Cancer Inst; 1986 Dec; 77(6):1309-13. PubMed ID: 3099048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH; McEntee MF; Whelan J
    Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.
    Hull MA; Booth JK; Tisbury A; Scott N; Bonifer C; Markham AF; Coletta PL
    Br J Cancer; 1999 Mar; 79(9-10):1399-405. PubMed ID: 10188882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
    Meyskens FL; Gerner EW
    Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
    Kettunen HL; Kettunen AS; Rautonen NE
    Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.